Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Fresenius reported EUR9.44B in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Akzo Nobel AKZA:NA EUR 2.48B 28M
Alcon AG ALC:SW USD 2.08B 66M
AstraZeneca AZN:LN USD 8.33B 1.78B
BASF BAS:GR EUR 18.12B 1.08B
Bayer BAYN:GR EUR 11.42B 848M
Demant A/s WDH:DC DKK 8.59B 680M
E.ON EOAN:GR EUR 33.04B 3.87B
Essilor EI:FP EUR 11.05B 771M
Fresenius FRE:GR EUR 9.44B 518M
Fresenius Medical Care FME:GR EUR 4.44B 201.87M
Getinge GETIB:SS SEK 6.24B 1.43B
Givaudan GIVN:VX CHF 2.98B 37M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
GN Store Nord GN:DC DKK 4.14B 688M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Lonza Group LONN:SW CHF 2.35B 8M
Novartis NOVN:VX USD 10.35B 700M
Philips PHIA:NA EUR 4.75B 501M
Roche Holding ROG:VX CHF 25.06B 4.31B
RWE RWE:GR EUR 7.35B 6.14B
Smith & Nephew PLC SN/:LN USD 2.41B 49M